Eam Global Investors LLC Axonics, Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $1.7 Million - $2.29 Million	29,369 New	29,369 $2.07 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $850,970 - $1.25 Million	-17,016 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $1.01 Million - $1.34 Million	17,016 New	17,016 $1.11 Million
Q4 2019 Feb 10, 2020	SELL	$19.57 - $28.96 $1.21 Million - $1.79 Million	-61,913 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$13.32 - $24.35 $824,681 - $1.51 Million	61,913 New	61,913 $1.48 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.